BFTI announces the signing of a contract for enhanced automated microscope, reagent and incubation chamber design with an established bio-tech design firm.SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Aug. 29, 1996--Bio Fluorescent Technologies Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB:BFTI BFTI Brownfields Tax Incentive ) (BFTI) Thursday announced that it has completed a contract agreement with SANNES & Associates Inc. to enhance the development of the BFTI PAK PAK, n.pr See pyridoxal-alpha-ketoglutarate. system, which is an antigen based HIV testing HIV test Various tests have been used to detect HIV and production of antibodies thereto; some HTs shown below are no longer actively used, but are listed for completeness and context. See HIV, Immunoblot. system. SANNES & Associates principals have extensive research, product development and product introduction skills. Their professional careers have given them firsthand first·hand adj. Received from the original source: firsthand information. first knowledge of these functions with major pharmaceutical and medical equipment manufacturing companies. As part of the agreement with SANNES, BFTI has given them the charge to expand BFTI's technology markets to include a wide range of viral and infectious diseases infectious diseases: see communicable diseases. . BFTI anticipates concluding, in the near future, an additional contract agreement with a nationally known West Coast based scientific instrument and optical development company that specializes in imaging and robotics. BFTI's management has expanded the company's core market to include a broader range of viral and infectious diseases and has sought out the best possible technology development companies to assure a higher degree of success. Management views these contracts as a significant first step in development and implementation of the company's expanded marketing plan. These two firms have extensive experience at developing, and more importantly, introducing, successful products to BFTI's target markets. This experience, gained while working for major industry players, will enhance BFTI's chances of introducing its products in a timely manner and with a higher degree of probable success. Management cautions that substantial additional financing will be required to implement the company's expanded vision of its markets. Bio Fluorescent Technologies Inc. is an international marketing company specializing in leading edge human screening and confirmatory immuno assays including HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. . CONTACT: Bio Fluorescent Technologies Inc., Scottsdale George, 800/870-1233 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion